Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.

Saved in:
Bibliographic Details
Title: Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.
Authors: Zhou H; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China., Xiang W; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China., Zhou G; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China., Rodrigues-Lima F; Université Paris Cité, CNRS, Unité de Biologie Fonctionnelle Et Adaptative, 75013, Paris, France., Guidez F; Université Paris Cité, Institut de Recherche Saint Louis INSERM UMR_S1131, 75010, Paris, France., Wang L; Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China. liwang@hospital.cqmu.edu.cn.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Dec 07; Vol. 42 (1), pp. 23. Date of Electronic Publication: 2024 Dec 07.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1559-131X
DOI:10.1007/s12032-024-02575-3